Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

From AIDS to Zika: ‘What’s next?’ asked Dr. Anthony Fauci in keynote address at the 2017 ACR/ARHP Annual Meeting

Keri Losavio  |  Issue: December 2017  |  November 5, 2017

SAN DIEGO—The 2017 ACR/ARHP Annual Meeting kicked off on Nov. 4 with a rousing presentation by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID). A terrorist attack on U.S. soil, hurricane, cyberattack and pandemic were the four scenarios played out in late 2016, when NIAID conducted a tabletop exercise for the newly elected president’s incoming cabinet.

In this first year of Donald Trump’s presidency, three of these four potential disasters have already occurred: We’ve had a terrorist attack in Las Vegas. Hurricanes Harvey, Irma and Maria wreaked untold damage in Texas, Florida and Puerto Rico. And the extent of Russia’s cyberattacks and interference in the election is still being uncovered. “That leaves pandemic,” said Dr. Fauci.

Anthony S. Fauci, MD (NIAID)

Anthony S. Fauci, MD (NIAID)

In Dr. Fauci’s keynote address, Emerging & Reemerging Infectious Diseases: From AIDS to Zika, he recapped what the world has learned in the past 30-odd years from our experience with infectious diseases, such as HIV/AIDS, influenza, SARS, West Nile, Ebola and Zika.

Dr. Fauci was appointed director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose and treat established infectious diseases. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The NIAID budget for fiscal year 2017 is approximately $4.9 billion.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Fauci has advised five presidents and the U.S. Department of Health and Human Services on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief, a program that has saved millions of lives throughout the developing world.

AIDS/HIV
The AIDS epidemic was the topic of Dr. Fauci’s first appearance before Congress following his appointment to NIAID by President Ronald Reagan. He said, “… because we do not know the cause of this syndrome, any assumption that the syndrome will remain restricted to a particular segment of our society is truly an assumption without scientific basis.”

As of 2016, globally, 76.1 million people have been infected with HIV, and 35 million people have died from AIDS-related illnesses—1 million died in 2016 alone. But that’s only part of the picture. 36.7 million people are living with HIV. That’s right, living with the disease. Funding for research made the difference.

In fact, following diagnosis in today’s world, Dr. Fauci can tell patients that they have a life expectancy of 53 years. When Dr. Fauci was first reporting on AIDS/HIV to Congress, the cause was unknown, patients were diagnosed late into their illness and they had a life expectancy of 8 to 15 months. Today, if you assume a patient is diagnosed in their 20s, they have a near-normal life expectancy. That progress led Dr. Fauci to state an important lesson he’s learned in his career: “When we put resources into a disease, we can get results.”

Page: 1 2 3 | Single Page
Share: 

Filed under:Meeting Reports Tagged with:2017 ACR/ARHP Annual Meeting

Related Articles
    Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

    Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

    June 15, 2017

    Rheumatologists treating HIV patients in 2017 must think through many important factors as this population ages. As we continue to learn, rheumatologists must consider important drug–drug interactions, relatively uncommon rheumatological presentations of HIV, as well as specific diagnostic challenges. Working closely with infectious disease specialists is the best way to achieve optimum care for this…

    Ebola: Hemorrhagic Fever and Macrophage Activation Syndrome

    December 1, 2014

    Rheumatologists focus on similar clinical, laboratory findings to better
    understand pathobiology of Ebola infection

    HIV Infection: What Rheumatologists Need to Know

    HIV Infection: What Rheumatologists Need to Know

    June 15, 2015

    It has been nearly 35 years since the original descriptions of what now is recognized as AIDS (the acquired immune deficiency syndrome), an advanced form of infection secondary to the human immunodeficiency virus (HIV). The epidemic of HIV infection remains the singular most dramatic epidemic of our generation and will likely remain with us for…

    Why Rheumatologists Should Care about Zika: How It’s Transmitted & Spreading in the U.S.

    September 26, 2016

    Rheumatologists are already familiar with one mosquito-borne virus, chikungunya, whose presentation mimics arthritis. Now, with its recent spread to Puerto Rico and the Southeastern U.S., Zika, another mosquito-borne virus, has become an international public health concern. Sexual transmission of the virus was recently confirmed, expanding the virus’s threat…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences